Corporate Contact

Latest Financial Results

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2023

mail icon

Sign Up For Email Alerts

Receive updates straight into your inbox

Sign up today

Company Overview

We are a development-stage medical technology company headquartered in San Diego, California. Our focus is the creation of therapeutic solutions that overcome current limitations in healthcare.

Our candidate solutions include: the ImmunePrep™ platform to enhance the activity of antibody-based immunotherapies, ChemoPrep™ to improve the delivery of cancer chemotherapies, ChemoPure™ to reduce the post-treatment toxicity of chemotherapy, and Sigyn Therapy™ to treat pathogen-associated inflammatory disorders that are not addressed with drug therapies. 

Investor Contact Information


Sigyn Therapeutics, Inc.
2468 Historic Decatur Rd.
Suite 140
San Diego, CA 92106
T: (619) 353-0800

Investor Relations

Sigyn Therapeutics
Charlene Owen
General Corporate Inquiries
T: (619) 353-0800

Transfer Agent

VStock Transfer, LLC
18 Lafayette Place
Woodmere, New York 11598
T: (212) 828-8436
F: (646) 536-3179